I am a venture architect at Appel Sauce Studios, developing multiple ventures through licensed IP. Our core technology platform enables sustained, controlled, and local delivery of all types of modalities, including cells and biologics--addressing key challenges in synthetic biology deployment. I have a PhD in Materials Science & Engineering with expertise in engineering biomaterials to enhance the performance of embedded therapeutic agents. Previously, I led R&D at a new venture Syntis Bio and before that I was in the formulation development team at Moderna.

‍